Vyondys 53 Injection
Product Images NDC 60923-465

4 FDA label images from Sarepta Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vyondys 53 (NDC 60923-465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sarepta Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Golodirsen (Exo03 0015 01)

Structure Of Golodirsen (Exo03 0015 01)
Chemical structure of golodirsen, the active ingredient in Vyondys 53 injection 50 mg/mL by Sarepta Therapeutics, Inc. The image shows the molecular arrangement of golodirsen as detailed in the labeling.*
FDA Label Image

Vyondys 53 Logo (Exo03 0015 02)

Vyondys 53 Logo (Exo03 0015 02)
Vyondys 53 (golodirsen) Injection label showing the proprietary name and generic name with clear text and a simple graphic icon. The label indicates an intravenous injection form produced by Sarepta Therapeutics, Inc., matching the product NDC 60923-465.*
FDA Label Image

Principal Display Panel (Carton Label)

Principal Display Panel (Carton Label)
Packaging label for Vyondys 53 (golodirsen) Injection, 100 mg/2 mL (50 mg/mL), for intravenous infusion after dilution. The single-dose vial packaging from Sarepta Therapeutics, Inc. includes instructions to use a 0.2 micron in-line filter during infusion and storage directions to refrigerate at 2°C to 8°C (36°F to 46°F). The label also details vial contents and contact information.*
FDA Label Image

Principal Display Panel (Vial Label)

Principal Display Panel (Vial Label)
Label for Vyondys 53 (golodirsen) Injection, 100 mg/2 mL (50 mg/mL), single-dose vial. The label includes the product name, strength, dosage form, single use indication, and manufacturer information, listing Sarepta Therapeutics, Inc., Cambridge, MA. The NDC 60923-465-02 is visible alongside a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.